Single-dose radiation after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial tests a new, shorter radiation treatment given all at once after breast-conserving surgery for early-stage breast cancer. It is for people with small tumors that have not spread far, and aims to reduce side effects and visits to the clinic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer is stage 0, I, or II and the tumor was less than 3 cm (about 1.2 inches)
- The cancer has not spread to your lymph nodes (or only has tiny amounts of cancer in them)
- Your cancer is not triple negative (doctors will check this from your biopsy)
- You are older than 40
- You had breast-conserving surgery (lumpectomy) with clear margins (no cancer cells at the edge of removed tissue), and surgery was less than 12 weeks ago (or up to 20 weeks if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.